1000573-99-8 Usage
General Description
4-Bromo-3-chloro-2-nitroaniline is a chemical compound with the molecular formula C6H4BrClN2O2. It is a derivative of aniline and is characterized by the presence of bromine, chlorine, and nitro groups on the aromatic ring. 4-Bromo-3-chloro-2-nitroaniline is commonly used as an intermediate in the synthesis of various pharmaceuticals, dyes, and agricultural chemicals. It is also used in the manufacturing of organic pigments and as a reagent in chemical reactions. 4-Bromo-3-chloro-2-nitroaniline is a yellow crystalline solid with a slightly sweet odor and is considered to be harmful if ingested or inhaled, as well as being toxic to aquatic life.
Check Digit Verification of cas no
The CAS Registry Mumber 1000573-99-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,5,7 and 3 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1000573-99:
(9*1)+(8*0)+(7*0)+(6*0)+(5*5)+(4*7)+(3*3)+(2*9)+(1*9)=98
98 % 10 = 8
So 1000573-99-8 is a valid CAS Registry Number.
1000573-99-8Relevant articles and documents
BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING
-
Page/Page column 94, (2021/02/12)
A compound of formula (I); wherein: W is O or NH; A1 1 is CRAA or N; A22 is CRBB or N; A3A3 is CRCC or N; A44 is CRDD or N; where no more than two of A11, A
HETEROBICYCLIC COMPOUNDS FOR INHIBITING THE ACTIVITY OF SHP2
-
Paragraph 0897-0899, (2020/02/16)
A compound of formula (I):wherein Ring A, Q, R1,R2, R3, R4, R5, R6, R7, R8, R9, R10, R11,X, a,b, c and d are as defined in the specification.
COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS
-
Paragraph 0628, (2017/03/14)
Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I'" or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
